In the third part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

In the second part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

The move bolsters the CDMO’s commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish ...

In the first part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

The track-and-trace systems provider expands its life sciences portfolio by integrating the high-speed, adaptable ETF-300 ...

A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement ...

As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders ...

The latest wave of artificial intelligence (AI), digital health, and direct-to-patient (DTP) models have the potential to drive significant innovation, transform patient experiences, and redefine ...

The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

Fran Gregory, VP, emerging therapies, Cardinal Health, emphasizes the need for long-term outcomes tracking and robust health economic modeling to demonstrate the sustained value of advanced therapies ...